GlassScriptPhysician profile
Clark D Rogers
NPI 1649408105
$1,542.76
in general payments reported to CMS, 2019-2025
8 companies · $582 in 2025
The $582 reported for 2025 was more than what 81% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $32.78 · 2021: $249 · 2022: $278 · 2023: $232 · 2024: $28.48 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $554.13 | 2019-2025 | Mammomat B.Brilliant, Mammomat Revelation |
| Hologic INC | $320.35 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $285.11 | 2020-2025 | |
| Becton, Dickinson and Company | $148.05 | 2025 | Ultracor Breast Tissue Marker |
| Merit Medical Systems INC | $116.32 | 2022 | |
| Leica Microsystems INC. | $61.56 | 2021-2023 | Hydromark Breast Biopsy Site Marker |
| Hologic Sales and Service, LLC | $43.32 | 2023-2024 | 3dquorum, 3dimensions |
| Elucent Medical | $13.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.